P Romero Selected Research

P Romero Research Topics

Disease

32	Neoplasms (Cancer) 03/2016 - 01/2000
24	Melanoma (Melanoma, Malignant) 01/2016 - 01/2000
4	Infections 01/2004 - 11/2000
3	Testicular Neoplasms (Testicular Cancer) 07/2007 - 08/2000
3	Human Influenza (Influenza) 06/2001 - 10/2000
2	Breast Neoplasms (Breast Cancer) 01/2016 - 11/2000
2	Prostatic Neoplasms (Prostate Cancer) 03/2009 - 01/2009
2	Virus Diseases (Viral Diseases) 11/2005 - 03/2001
2	Carcinoma (Carcinomatosis) 12/2003 - 11/2000
2	Malaria 11/2000 - 10/2000
1	COVID-19 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	End Stage Liver Disease 11/2017
1	Primary Immunodeficiency Diseases 01/2017
1	Cystic Lymphangioma (Hygroma) 03/2016
1	Obesity 01/2012
1	Overweight 01/2012
1	Wounds and Injuries (Trauma) 05/2011
1	Pain (Aches) 05/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2007
1	Inflammation (Inflammations) 11/2006
1	Cataract (Cataracts) 05/2006
1	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2006
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2005
1	Central Serous Chorioretinopathy 12/2005
1	Neoplasm Metastasis (Metastasis) 01/2004
1	Hemorrhage 01/2004
1	Neutropenia 01/2004
1	Insulin Resistance 11/2001
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2001
1	Vesicular Stomatitis 08/2001

Drug/Important Bio-Agent (IBA)

21	Peptides (Polypeptides)IBA 01/2016 - 01/2000
15	AntigensIBA 01/2016 - 08/2000
10	MART-1 AntigenIBA 12/2001 - 01/2000
9	VaccinesIBA 03/2013 - 12/2000
8	Proteins (Proteins, Gene)FDA Link 01/2016 - 09/2000
7	EpitopesIBA 01/2016 - 07/2000
6	HLA-A*02:01 antigenIBA 09/2001 - 10/2000
5	Neoplasm Antigens (Tumor Antigens)IBA 09/2001 - 03/2001
4	HLA-A2 Antigen (HLA A2 Antigen)IBA 09/2001 - 01/2001
3	Monoclonal AntibodiesIBA 03/2001 - 11/2000
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2001 - 12/2000
2	Immunoglobulin Fab FragmentsIBA 03/2001 - 11/2000
2	Immunoglobulin FragmentsIBA 03/2001 - 11/2000
2	Cancer VaccinesIBA 01/2001 - 08/2000
1	AerosolsIBA 01/2022
1	AutoantibodiesIBA 01/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017
1	Tyrosine (L-Tyrosine)FDA Link 01/2016
1	Tannic Acid FDA Link 01/2016
1	Annexin A5IBA 01/2016
1	Interferon-gamma (Interferon, gamma)IBA 01/2016
1	Cytochromes c (Cytochrome c)IBA 01/2016
1	PolyphenolsIBA 01/2016
1	Caspase 3 (Caspase-3)IBA 01/2016
1	Toll-Like Receptor AgonistsIBA 03/2013
1	Poly I-CIBA 03/2013
1	CPG-oligonucleotideIBA 03/2013
1	FatsIBA 01/2012
1	CarbohydratesIBA 01/2012
1	Tissue Adhesives (Tissue Adhesive)IBA 05/2011
1	Sodium Glutamate (Accent)IBA 05/2008
1	SCP 1IBA 07/2007
1	Retinal Pigments (Pigments, Visual)IBA 12/2005
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2005
1	Ointments (Pastes)IBA 12/2005
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2004
1	Thrombin FDA Link 01/2004
1	IceIBA 01/2004
1	Cisplatin (Platino)FDA LinkGeneric 12/2003
1	Peptide Hydrolases (Proteases)FDA Link 11/2001
1	Insulin (Novolin)FDA Link 11/2001
1	Triglycerides (Triacylglycerol)IBA 11/2001
1	RibonucleoproteinsIBA 09/2001
1	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2001
1	Interferon-alpha (Interferon Alfa)IBA 08/2001
1	Peptide LibraryIBA 07/2001
1	LigandsIBA 07/2001
1	Monophenol Monooxygenase (Tyrosinase)IBA 04/2001
1	influenza matrix peptide (58-66)IBA 03/2001
1	SolutionsIBA 03/2001
1	Surface Antigens (Surface Antigen)IBA 03/2001
1	peptide NY-ESO-1 157-165IBA 03/2001
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2001
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 03/2001
1	Glycoproteins (Glycoprotein)IBA 01/2001

Therapy/Procedure

9	Immunotherapy 05/2008 - 01/2000
4	Radiotherapy 03/2009 - 12/2003
2	Therapeutics 01/2012 - 05/2008
2	Drug Therapy (Chemotherapy) 01/2004 - 12/2003
1	Liver Transplantation 11/2017
1	Transplantation 03/2016
1	Appendectomy 05/2011
1	Surgical Instruments (Clip) 05/2011
1	Sutures (Suture) 05/2011
1	Brachytherapy 01/2009
1	Operative Time 11/2006
1	Vitrectomy 05/2006
1	Injections 01/2004